Amesite (AMST) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 Oct, 2026Executive summary
Annual meeting scheduled for December 10, 2026, with six matters: two director elections, auditor ratification, reverse-split authority, private-offering issuance approval, say-on-pay, and say-on-pay frequency.
Record date is October 13, 2026; 6,549,851 common shares were outstanding, with one vote per share.
Meeting will be virtual; proxy materials are primarily delivered online to reduce printing costs and environmental impact.
Voting matters and shareholder proposals
Board recommends voting for both director nominees, auditor ratification, reverse-split authority, securities issuance, and say-on-pay; it recommends annual future say-on-pay votes.
Two Class III nominees, Gilbert S. Omenn and George Parmer, would each serve a three-year term; election requires a plurality of votes cast.
Proposals 2–5 require a majority of votes cast; for frequency, the one-, two-, or three-year option with the most votes cast prevails.
Rule 14a-8 proposals for the 2027 annual meeting must be received by June 16, 2027; director nomination notices are due August 12–September 11, 2027.
Board of directors and corporate governance
Board has five directors; four—Barbie Brewer, J. Michael Losh, George Parmer, and Gilbert S. Omenn—were deemed independent.
Ann Marie Sastry serves as CEO, President, and Board Chair; the board will continue reviewing its leadership structure and governance policies.
Board met four times in FY2026; all directors attended at least 75% of board and applicable committee meetings.
Audit, compensation, and governance/nominating committees have written charters; independent directors perform the governance and nominating committee function.
Directors and officers are barred from hedging securities and, subject to limited exceptions, pledging them; an insider-trading policy and code of conduct are in place.
Latest events from Amesite
- Proxy seeks director elections, reverse-split authority and financing flexibility.AMST
Proxy filing - Four proposals seek director re-election, a reverse split and financing flexibility.AMST
Proxy filing - Revenue increased and losses narrowed, but going concern risks persist amid ongoing cash burn.AMST
Q4 2026 - All proposals passed as the company targets B2B healthcare growth with scalable AI solutions.AMST
AGM 2026 - Annual meeting seeks approval for director elections, auditor, equity plan, and share issuances.AMST
Proxy filing - Annual meeting to vote on directors, auditor, equity plan amendment, and warrant exercises.AMST
Proxy filing - Auditors flagged going concern risks; offering led by Laidlaw & Company (UK) Ltd.AMST
Registration filing - Revenue increased and net loss narrowed, but going concern risks persist despite new capital.AMST
Q3 2026 - AI healthcare firm offers 4.8M shares for resale, with viability dependent on warrant exercise proceeds.AMST
Registration filing